Le Lézard
Classified in: Health, Business
Subject: TDS

410 Medical Awarded Emergency Medicine Contract with Premier

DURHAM, N.C., Dec. 5, 2019 /PRNewswire/ -- 410 Medical, a medical device company developing innovative technologies for critical care, has been awarded a group purchasing agreement for Emergency Medicine Products with Premier, Inc. Effective October 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for 410 Medical's innovative LifeFlow product. Earlier this year, LifeFlow was selected as a showcase product at the 2019 Premier Innovation Celebration due to its uniqueness and potential to improve patient care.

410 Medical, Inc., a medical device company focused on developing innovative technologies for the resuscitation of critically ill patients. (PRNewsfoto/410 Medical, Inc.)

LifeFlow is a simple hand-held tool for rapid, controlled delivery of a fluid bolus in critically ill patients.  With LifeFlow, health care providers are able to set up and deliver a targeted fluid bolus up in less than 4 minutes, up to 10x faster than standard fluid delivery methods.  A published probability study demonstrated a significant potential economic benefit for hospitals, suggesting over $1.5M in savings for every 500 patients treated.

"We know that early fluid resuscitation improves outcomes in critical patients, such as those suffering from sepsis or shock," said Kyle Chenet, President and CEO of 410 Medical.  "This new agreement is an exciting next step in making LifeFlow more accessible to clinicians and patients utilizing Premier's vast network, with the collaborative intention of improving healthcare delivery and outcomes."

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 175,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

About 410 Medical, Inc.
Founded in 2013, 410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care for critically ill patients. 410 Medical's first product, LifeFlow, is designed to enhance the speed and efficiency of fluid resuscitation, improving care for patients with life-threatening illnesses such as sepsis and shock. LifeFlow was cleared by the FDA for human use in 2016. For more information, visit www.410medical.com.

SOURCE 410 Medical, Inc.

These press releases may also interest you

at 08:30
The "2020 Europe Respiratory Disease Testing Market: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts - Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis" report has been added...

at 08:25
The "2020 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies" report has been added...

at 08:25
Systech, the global technology leader in brand protection and digital product authentication, announced today it has successfully upgraded serialization lines for Takeda to meet new Russian serialization regulations. October 1, 2019 was the first...

at 08:25
Cannabics Pharmaceuticals Inc. , a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a series of tests conducted at the company's High Through-put Screening (HTS) facility in Israel, it has...

at 08:20
The "2020 Europe Cell Surface Markers: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts by Country, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers" report has been added to...

at 08:17
AbbVie Inc. ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance,...

News published on 5 december 2019 at 08:30 and distributed by: